Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Orvosi Hetilap
|
April 26, 1981
[Removal of a foreign body from the stomach using an endoscope]
I Sawinsky
International Journal of Clinical Pharmacology and Biopharmacy
|
October 1, 1976
Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis
J P Radó, I Sawinsky, E Juhos
International Journal of Clinical Pharmacology and Biopharmacy
|
October 1, 1975
Dose-response relations in drug-induced inappropriate secretion of ADH: effects of clofibrate and carbamazepine
J P Radó, E Juhos, I Sawinsky
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
May 1, 1976
Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop
J P Radó, I Sawinsky, E Juhos
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 1, 1974
Interference of triameterene with cortisol determination in urine
J P Radó, L Végh, I Sawinsky
Orvosi Hetilap
|
April 28, 1974
[Intraluminal duodenal diverticulum causing differential diagnostic problems]
I Balogh, I Hajdú, I Sawinsky, et al.
Radiologia Diagnostica
|
January 1, 1975
[Interlumen duodenal diverticulum (author's transl)]
I Balogh, I Hajdu, I Sawinsky, et al.
Orvosi Hetilap
|
February 11, 1973
[Diabetic osteoarthropathy]
S Forgács, T Solymosi, T Szabó, et al.
Acta Diabetologica Latina
|
May 1, 1974
Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus
J P Radó, L Szende, J Marosi, et al.
Oncology
|
January 1, 1987
Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) Study
S Kerpel-Fronius, F Gyergyay, I Hindy, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Orvosi Hetilap
|
April 26, 1981
[Removal of a foreign body from the stomach using an endoscope]
I Sawinsky
International Journal of Clinical Pharmacology and Biopharmacy
|
October 1, 1976
Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis
J P Radó, I Sawinsky, E Juhos
International Journal of Clinical Pharmacology and Biopharmacy
|
October 1, 1975
Dose-response relations in drug-induced inappropriate secretion of ADH: effects of clofibrate and carbamazepine
J P Radó, E Juhos, I Sawinsky
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
May 1, 1976
Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop
J P Radó, I Sawinsky, E Juhos
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 1, 1974
Interference of triameterene with cortisol determination in urine
J P Radó, L Végh, I Sawinsky
Orvosi Hetilap
|
April 28, 1974
[Intraluminal duodenal diverticulum causing differential diagnostic problems]
I Balogh, I Hajdú, I Sawinsky, et al.
Radiologia Diagnostica
|
January 1, 1975
[Interlumen duodenal diverticulum (author's transl)]
I Balogh, I Hajdu, I Sawinsky, et al.
Orvosi Hetilap
|
February 11, 1973
[Diabetic osteoarthropathy]
S Forgács, T Solymosi, T Szabó, et al.
Acta Diabetologica Latina
|
May 1, 1974
Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus
J P Radó, L Szende, J Marosi, et al.
Oncology
|
January 1, 1987
Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) Study
S Kerpel-Fronius, F Gyergyay, I Hindy, et al.
Page
of 2